CorVel Past Earnings Performance

Past criteria checks 3/6

CorVel has been growing earnings at an average annual rate of 13.1%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been growing at an average rate of 8.5% per year. CorVel's return on equity is 28.8%, and it has net margins of 9.6%.

Key information

13.1%

Earnings growth rate

14.7%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate8.5%
Return on equity28.8%
Net Margin9.6%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Oct 22
Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Aug 27
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

Jul 30
Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

Jul 12
CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 25
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Apr 07
CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

Mar 19
Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Jan 10
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

Dec 23
The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

Dec 05
With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Oct 10
CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Sep 01
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

Jul 10
We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 11
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

Mar 24
If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Jan 06
A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Dec 19
Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

Sep 21
CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Aug 25
We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

CorVel GAAP EPS of $0.94, revenue of $176M

Aug 02

Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Jun 23
Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

May 18
Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

Mar 21
CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Feb 14
With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Revenue & Expenses Breakdown

How CorVel makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:CRVL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2484682830
30 Jun 2481778800
31 Mar 2479576770
31 Dec 2377475750
30 Sep 2375175730
30 Jun 2373369710
31 Mar 2371966740
31 Dec 2270468710
30 Sep 2269065710
30 Jun 2267066700
31 Mar 2264666680
31 Dec 2162062670
30 Sep 2159759670
30 Jun 2157655660
31 Mar 2155346640
31 Dec 2055443640
30 Sep 2056141640
30 Jun 2057242650
31 Mar 2059247650
31 Dec 1959647660
30 Sep 1959448650
30 Jun 1959548630
31 Mar 1959647630
31 Dec 1858844620
30 Sep 1858343620
30 Jun 1857139610
31 Mar 1855836590
31 Dec 1754835590
30 Sep 1753632570
30 Jun 1752831580
31 Mar 1751929570
31 Dec 1651328580
30 Sep 1650928580
30 Jun 1650529570
31 Mar 1650429580
31 Dec 1549727560
30 Sep 1549628560
30 Jun 1549527550
31 Mar 1549329540
31 Dec 1449131540
30 Sep 1448933540
30 Jun 1448534530
31 Mar 1447934520
31 Dec 1347134500

Quality Earnings: CRVL has high quality earnings.

Growing Profit Margin: CRVL's current net profit margins (9.6%) are lower than last year (10%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CRVL's earnings have grown by 13.1% per year over the past 5 years.

Accelerating Growth: CRVL's earnings growth over the past year (9.1%) is below its 5-year average (13.1% per year).

Earnings vs Industry: CRVL earnings growth over the past year (9.1%) did not outperform the Healthcare industry 10.3%.


Return on Equity

High ROE: CRVL's Return on Equity (28.8%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies